0001179110-19-007731.txt : 20190614 0001179110-19-007731.hdr.sgml : 20190614 20190614180009 ACCESSION NUMBER: 0001179110-19-007731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190612 FILED AS OF DATE: 20190614 DATE AS OF CHANGE: 20190614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Albers Jeffrey W. CENTRAL INDEX KEY: 0001638474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 19900007 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORP. STREET 2: 215 FIRST STREET, SUITE 340/350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2019-06-12 0 0001597264 Blueprint Medicines Corp BPMC 0001638474 Albers Jeffrey W. C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 1 1 0 0 CEO and President Common Stock 2019-06-12 4 M 0 20000 1.87 A 48961 D Common Stock 2019-06-12 4 S 0 9191 85.72 D 39770 D Common Stock 2019-06-12 4 S 0 4859 84.61 D 34911 D Common Stock 2019-06-12 4 S 0 4050 83.81 D 30861 D Common Stock 2019-06-12 4 S 0 1900 82.37 D 28961 D Stock Option (Right to Buy) 1.87 2019-06-12 4 M 0 20000 0 D 2024-07-30 Common Stock 20000 43080 D Effected pursuant to a trading plan adopted on December 11, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.16 to $86.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.13 to $85.12 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.21 to $84.12 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.07 to $82.73 per share. This option was granted on July 30, 2014. This option vested as follows: (i) 42,845 shares vested in four installments at a rate of 6,974 shares on September 21, 2016, and 11,957 shares on each of October 21, 2016 and November 21, 2016, and 11,957 on December 21, 2016; (ii) 90,010 shares vested in eight installments at a rate of 6,311 shares on May 21, 2017 and 11,957 shares on each of June 21, 2017, July 21, 2017, August 21, 2017, September 21, 2017, October 21, 2017, November 21, 2017 and December 21, 2017; and (iii) 30,225 shares vested in three installments at a rate of 6,311 shares on May 21, 2018, 11,957 shares on June 21, 2018 and 11,957 shares on July 21, 2018. /s/ Christopher Frankenfield, Attorney-in-Fact 2019-06-14